Non-Cytotoxic Radiosensitizers in Brain Radiotherapy: Journey Till the First Decade of this Millennium

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|12|3|260-278

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.3, 2012-03, pp. : 260-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 5, 2010-01 ,pp. : 504-526

Bentham Science Publishers

Access to resources Recommend Favorite

DLT may not be best metric for trials of non-cytotoxic agents

By  

Reactions Weekly, Vol. 1, Iss. 1316, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Novel Non-Cytotoxic Therapy in Ovarian Cancer: Current Status and Future Prospects

By Martin Lainie   Schilder Russell J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 9, 2006-10 ,pp. : 955-966

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Cationic Lipid-Coated Gold Nanoparticles as Efficient and Non-Cytotoxic Intracellular siRNA Delivery Vehicles

By Kong Won   Bae Ki   Jo Sung   Kim Jee   Park Tae  

Pharmaceutical Research, Vol. 29, Iss. 2, 2012-02 ,pp. : 362-374

Springer Publishing Company

Access to resources Recommend Favorite

Dinuclear Cyclam Complex as a Non-Cytotoxic, Anti-Hyperurecemic Lead: In vitro to In vivo Studies

By  

Medicinal Chemistry, Vol. 13, Iss. 6, 2017-08 ,pp. : 585-591

Bentham Science Publishers

Access to resources Recommend Favorite